Association Between the Lockdown for SARS-CoV-2 (COVID-19) and Reduced Surgical Site Infections after Vascular Exposure in the Groin at Two Italian Academic Hospitals.


Journal

Annals of vascular surgery
ISSN: 1615-5947
Titre abrégé: Ann Vasc Surg
Pays: Netherlands
ID NLM: 8703941

Informations de publication

Date de publication:
Feb 2023
Historique:
received: 11 08 2022
revised: 28 09 2022
accepted: 29 09 2022
pubmed: 22 11 2022
medline: 25 1 2023
entrez: 21 11 2022
Statut: ppublish

Résumé

The aim of this study was to evaluate whether the scrupulous hygiene rules and the restriction of contacts during the lockdown owing to the COVID-19 pandemic affected the rate and severity of surgical site infections (SSI) after vascular exposure in the groin at two Italian University Hospitals. Starting from March 2020, strict hygiene measures for protection of health care workers (HCW) and patients from COVID-19 infection were implemented, and partly lifted in July 2020. The main exposure for analysis purposes was the period in which patients were operated. Accordingly, study subjects were divided into two groups for subsequent comparisons (preCOVID-19 era: March-June 2018-2019 versus COVID-19 era: March-June 2020). The primary endpoint was the occurrence of superficial and/or deep SSI within 30 days after surgery. The Centers for Disease Control and Prevention definitions were used to classify superficial and deep SSI. A total of 194 consecutive patients who underwent vascular exposure in the groin were retrospectively analyzed. Of those, 60 underwent surgery from April 1, 2018 to June 30 of the same year; 83 from April 1, 2019 to June 30 of the same year; and 51 from April 1, 2020 to June 30 of the same year. The mean age of the study cohort was 75 years and 140 (72%) were males. Patients who were operated in the COVID-19 era were less likely to develop SSI (10% vs. 28%; P = 0.008), including both deep SSI (4% vs. 13%; P = 0.04) and superficial SSI (6% vs. 15%; P = 0.05). After multivariate adjustments, being operated in the COVID-19 era was found to be a negative predictor for development of an SSI (odds ratio [OR] = 0.31; 95% confidence interval [CI] = 0.09-0.76; P < 0.001) or deep SSI (OR = 0.21; 95% CI = 0.03-0.98; P < 0.001). Operative time was also found as independent predictor for the development of deep SSI (OR = 1.21; 95%CI = 1.21-1.52; P = 0.02). Using binary logistic regression, there were no independent predictors of superficial SSI that could be identified. Vascular exposure in the groin carries a non-negligible risk of SSI. In this study, we provided important insights that are simple and easily viable precautions (such as the universal use of surgical masks both for patients and health care professionals during wound care, the widespread diffusion of hand sanitizers, and the reduction of the number of visitors in the surgical wards) could be promising and safe tools for SSI risk reduction.

Sections du résumé

BACKGROUND BACKGROUND
The aim of this study was to evaluate whether the scrupulous hygiene rules and the restriction of contacts during the lockdown owing to the COVID-19 pandemic affected the rate and severity of surgical site infections (SSI) after vascular exposure in the groin at two Italian University Hospitals.
METHODS METHODS
Starting from March 2020, strict hygiene measures for protection of health care workers (HCW) and patients from COVID-19 infection were implemented, and partly lifted in July 2020. The main exposure for analysis purposes was the period in which patients were operated. Accordingly, study subjects were divided into two groups for subsequent comparisons (preCOVID-19 era: March-June 2018-2019 versus COVID-19 era: March-June 2020). The primary endpoint was the occurrence of superficial and/or deep SSI within 30 days after surgery. The Centers for Disease Control and Prevention definitions were used to classify superficial and deep SSI.
RESULTS RESULTS
A total of 194 consecutive patients who underwent vascular exposure in the groin were retrospectively analyzed. Of those, 60 underwent surgery from April 1, 2018 to June 30 of the same year; 83 from April 1, 2019 to June 30 of the same year; and 51 from April 1, 2020 to June 30 of the same year. The mean age of the study cohort was 75 years and 140 (72%) were males. Patients who were operated in the COVID-19 era were less likely to develop SSI (10% vs. 28%; P = 0.008), including both deep SSI (4% vs. 13%; P = 0.04) and superficial SSI (6% vs. 15%; P = 0.05). After multivariate adjustments, being operated in the COVID-19 era was found to be a negative predictor for development of an SSI (odds ratio [OR] = 0.31; 95% confidence interval [CI] = 0.09-0.76; P < 0.001) or deep SSI (OR = 0.21; 95% CI = 0.03-0.98; P < 0.001). Operative time was also found as independent predictor for the development of deep SSI (OR = 1.21; 95%CI = 1.21-1.52; P = 0.02). Using binary logistic regression, there were no independent predictors of superficial SSI that could be identified.
CONCLUSIONS CONCLUSIONS
Vascular exposure in the groin carries a non-negligible risk of SSI. In this study, we provided important insights that are simple and easily viable precautions (such as the universal use of surgical masks both for patients and health care professionals during wound care, the widespread diffusion of hand sanitizers, and the reduction of the number of visitors in the surgical wards) could be promising and safe tools for SSI risk reduction.

Identifiants

pubmed: 36404473
pii: S0890-5096(22)00642-2
doi: 10.1016/j.avsg.2022.09.065
pmc: PMC9613778
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

60-67

Informations de copyright

Copyright © 2022 Elsevier Inc. All rights reserved.

Références

J Infect Chemother. 2019 Sep;25(9):669-680
pubmed: 31182331
Anesthesiology. 2019 Oct;131(4):765-768
pubmed: 31246605
World J Emerg Surg. 2022 Mar 17;17(1):17
pubmed: 35300731
World J Emerg Surg. 2020 Feb 10;15(1):10
pubmed: 32041636
J Res Med Sci. 2019 Oct 25;24:90
pubmed: 31741662
Eur J Vasc Endovasc Surg. 2021 Apr;61(4):636-646
pubmed: 33423912
Int Wound J. 2021 Apr;18(2):164-175
pubmed: 33236858
J Vasc Surg. 2021 Nov;74(5):1668-1672
pubmed: 34019988
Anaesthesia. 2020 Jun;75(6):724-732
pubmed: 32221973
Updates Surg. 2020 Dec;72(4):1263-1271
pubmed: 32926340
Ann Vasc Surg. 2022 Jul;83:97-107
pubmed: 35247541
Eur J Vasc Endovasc Surg. 2020 Sep;60(3):489-490
pubmed: 32798205
J Vasc Surg. 2017 Dec;66(6):1814-1819
pubmed: 28865981
Cochrane Database Syst Rev. 2018 Feb 06;2:CD012653
pubmed: 29406579
Eur J Vasc Endovasc Surg. 2020 Mar;59(3):339-384
pubmed: 32035742
Eur J Vasc Endovasc Surg. 2021 Aug;62(2):258-266
pubmed: 34246547
Semin Vasc Surg. 2015 Sep-Dec;28(3-4):201-7
pubmed: 27113288
World J Emerg Surg. 2020 Feb 18;15(1):13
pubmed: 32070390
Eur J Vasc Endovasc Surg. 2016 Dec;52(6):758-763
pubmed: 27771318
World J Emerg Surg. 2018 Aug 17;13:37
pubmed: 30140304
Antibiotics (Basel). 2022 Jan 20;11(2):
pubmed: 35203737

Auteurs

Mario D'Oria (M)

Division of Vascular and Endovascular Surgery, Cardiovascular Department, University Hospital of Trieste ASUGI, Trieste, Italy. Electronic address: mario.doria88@outlook.com.

Gian Franco Veraldi (GF)

Department of Vascular Surgery, University Hospital and Trust of Verona, Italy.

Davide Mastrorilli (D)

Department of Vascular Surgery, University Hospital and Trust of Verona, Italy.

Luca Mezzetto (L)

Department of Vascular Surgery, University Hospital and Trust of Verona, Italy.

Cristiano Calvagna (C)

Division of Vascular and Endovascular Surgery, Cardiovascular Department, University Hospital of Trieste ASUGI, Trieste, Italy.

Jacopo Taglialavoro (J)

Division of Vascular and Endovascular Surgery, Cardiovascular Department, University Hospital of Trieste ASUGI, Trieste, Italy.

Silvia Bassini (S)

Division of Vascular and Endovascular Surgery, Cardiovascular Department, University Hospital of Trieste ASUGI, Trieste, Italy.

Filippo Griselli (F)

Division of Vascular and Endovascular Surgery, Cardiovascular Department, University Hospital of Trieste ASUGI, Trieste, Italy.

Lorenzo Grosso (L)

Department of Vascular Surgery, University Hospital and Trust of Verona, Italy.

Andrea Carere (A)

Faculty of Medicine, University of Trieste Medical School, Italy.

Alessia D'Andrea (A)

Division of Vascular and Endovascular Surgery, Cardiovascular Department, University Hospital of Trieste ASUGI, Trieste, Italy.

Sandro Lepidi (S)

Division of Vascular and Endovascular Surgery, Cardiovascular Department, University Hospital of Trieste ASUGI, Trieste, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH